SBIR/STTR Research Award

Omics Based Assays for Screening Chemical Toxicity Using Stem Cells

Award identifier 2273c6e381f79bcdf70045517ac62219987c2121f1394d75262c3fe5d292f2d2Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,502,500

Program and phase

SBIR · Phase II

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NEWOMICS INC.
Proposal award date
2016-02-01
Contract end date
2018-01-31
UEI
LMKSNZ862R36
Solicitation number
ES15-006
Topic code
NIEHS

Research abstract

DESCRIPTION provided by applicant There is a paradigm shift in testing and modeling of chemical toxicity Current toxicology calls for cell based vs animal based evidence based and Omics based assays Mesenchymal stem cells MSC play important roles in the maintenance and repair of various tissues including bone cartilage and muscle MSCs are also found in circulating blood and participate in the wound healing process Therefore MSC is arguably one of the most physiologically relevant adult stem cells for chemical toxicology In response to RFA ES Newomics Inc proposes this SBIR Phase II project to complete development of its product high throughput Omics based assays to evaluate the effects of chemical toxicants on proliferation and differentiation of stem cells The Phase II project is buil upon the extremely promising results generated from our Phase I project In Phase I we have demonstrated a robust and universal two stage workflow for Omics based and high throughput screening of chemical toxicity using human MSCs We have also discovered several pathways and networks for mechanistic understanding of chemical toxicity on MSCs In Phase II we will scale up our toxicity assays for MSCs using the Tox k library develop Omics chips and validate their applications in Omics based assays for chemical toxicity and provide a toolkit for screening the effects of chemical toxicants on cell differentiation Once developed our platforms and solutions may be utilized for chemical toxicity studies of other types of stem cells such as ESCs and iPSCs to help prioritize chemicals for in depth toxicological evaluation and to even help develop new intervention strategies for mitigating chemical toxicity thereby contributing to public health PUBLIC HEALTH RELEVANCE Cutting edge technologies enable breakthroughs in biomedical research Developments of mass spectrometry based microchip platforms for screening chemical toxicity using stem cells will help prioritize chemicals for in depth toxicological evaluation thereby providing new strategies for impacting public health

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

14 SBIR/STTR records share this UEI (2012–2025). Reported award amounts total $14,707,662. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.